Specifically for mismatch repair (MMR) genes, a retrospective study of 26 cSCC patients treated with a PD-1 inhibitor found MLH1 and MSH6 mutations in two responders, and a case report found a MLH1 mutation in a complete responder [22,26]. Here, MLH1 is linked to skin squamous cell carcinoma.